Multiple studies have shown that CD82/KAI1 serves as a key metastasis suppressor in various solid malignancies, such as renal (95), prostate (96), breast (97), and hepatocellular cancers (98). This evidence concerns the gene CD82 and hepatocellular carcinoma.